Evidence map›Paper›PMID 19661384›Full record

ArticleThe Journal of molecular diagnostics : JMD2009

Visual format for detection of Mycobacterium tuberculosis and M. bovis in clinical samples using molecular beacons.

Parameet Kumar, Kapili Nath, Bimba Rath, Manas K Sen, Potharuju Vishalakshi, Devender S Chauhan, Vishwa M Katoch, Sarman Singh, Sanjay Tyagi, Vishnubhatla Sreenivas and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Validation of a real-time PCR assay for the molecular identification of Mycobacterium tuberculosis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2014
    Article
  3. Article
  4. Molecular beacons in diagnostics.F1000 medicine reports · 2012
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Parameet KumarDepartment of Biotechnology, All India Institute of Medical Sciences, New Delhi-110029, India. hkp1000@gmail.com
Kapili Nath
Bimba Rath
Manas K Sen
Potharuju Vishalakshi
Devender S Chauhan
Vishwa M Katoch
Sarman Singh
Sanjay Tyagi
Vishnubhatla Sreenivas
Hanumanthappa K Prasad
Department of Biotechnology · INKalawati Saran Children's Hospital · INGovernment of India · INAll India Institute of Medical Sciences · INNational JALMA Institute for Leprosy & Other Mycobacterial Diseases · INSafdarjang Hospital · IN

Funding

TUBERCULOSIS RESEARCH MATERIALS AND VACINE TESTINGN01AI075320 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · 1997 to 2004
$980k
NIAID NIH HHS AI-75320
6 · The paper itself

Abstract

A real-time polymerase chain reaction (PCR) assay for the direct identification of Mycobacterium tuberculosis and M. bovis using molecular beacons was developed. The assay was modified for use in regular thermal cyclers. Molecular beacons that were specific for M. tuberculosis (Tb-B) and M. bovis (Bo-B) were designed. The fluorescence of the target PCR product-molecular beacon probe complex was detected visually using a transilluminator. The results were then compared with those of conventional multiplex PCR (CM-PCR) assays and biochemical identification. The detection limit of Tb-B and Bo-B beacons was 500 fg and 50 fg by the visual format and real-time PCR assay, respectively, compared with 5 pg by CM-PCR assay. Pulmonary and extrapulmonary samples were examined. The agreement between culture and the two assays was very good in sputum samples and fair in extrapulmonary samples. The agreement between clinical diagnoses with the two assays was moderate in extrapulmonary samples. There was very good agreement between CM-PCR and visual format assays for all samples used in the study. Concordance in the identification of isolates by the visual, CM-PCR assay, and biochemical identification was seen. Hence, the use of molecular beacon detection of M. tuberculosis and M. bovis in clinical samples is feasible by setting up two asymmetric PCRs concurrently. The assay is sensitive, specific, simple to interpret, and takes less than 3 hours to complete.

Indexed as

HumansMycobacterium bovisMycobacterium tuberculosisPolymerase Chain ReactionReproducibility of ResultsSensitivity and SpecificitySputumTuberculosis

Identifiers

PMID19661384
PMCPMC2729840
OpenAlexW2160584938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.